Supplier profile
Zentiva Pharma GmbH
Every public-sector award we hold for this supplier, across Germany, from 13 Aug 2014 to 25 Jul 2026.
Awards won
195
all time
Attributed value
€1.7m
172 shared, unvalued
Buyers
27
public bodies
Active
2014–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 57 | not attributable |
| GWQ ServicePlus AG | 26 | not attributable |
| IKK classic | 23 | €1.0m |
| Techniker Krankenkasse | 16 | €1 |
| AOK Baden-Württemberg | 12 | €663k |
| AOK Nordost – Die Gesundheitskasse | 10 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 8 | not attributable |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Stabsbereich Recht; Referat Zentrale Vergabestelle | 5 | not attributable |
| Vergabestelle der AOK – Rheinland-Pfalz/Saarland – Die Gesundheitskasse | 5 | not attributable |
| BARMER Beschaffung und Vergabe | 4 | not attributable |
What they win
Awards
Showing 51–75 of 195 awards we hold
- Germany – Pharmaceutical products – Generikaausschreibung ↗BARMER Beschaffung und Vergabeshared awardawarded 1 Jul 2025
- Abirateron (FTA; 446.32 mg) ↗BARMER Beschaffung und Vergabeshared awardawarded 30 Jun 2025
- Germany – Pharmaceutical products – Generika-Ersatzkassen 24 ↗DAK-Gesundheitshared awardawarded 18 Jun 2025
- 101 - DAK / KKH - Acarbose - A10BF01 ↗DAK-Gesundheitshared awardawarded 17 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Germany – Pharmaceutical products – 32. Generikaausschreibung (2;3er) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Aripiprazol (LSE) ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- 001 | Azelastin + Fluticason Nasenspray [1] ↗IKK classicshared awardawarded 8 Jan 2025
- Amlodipin ↗AOK Baden-Württembergshared awardawarded 30 Dec 2024
- Azelastin und Fluticason 17-propionat - TK, hkk, HEK (ATC-Code: R01AD28) ↗Techniker Krankenkasseshared awardawarded 23 Dec 2024
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 ↗PBMG eGawarded 2 Dec 2024
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 21 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 13 Nov 2024
- Amoxicillin fest (EU) - TK, hkk, HEK (ATC-Code: J01CA04) ↗Techniker Krankenkasseshared awardawarded 13 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Timolol + Brinzolamid, ATC S01ED67 für die Zeit 01.11.2024 - 31.10.2026 ↗DAK-Gesundheitshared awardawarded 1 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dasatinib (ausschl. Wirkstärke 100 mg in der Normgröße N2 und N3, ATC L01EA02 f. d. Z. 01.11.24 - 31.10.26 ↗DAK-Gesundheitshared awardawarded 1 Nov 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Timolol + Brinzolamid, ATC S01ED67 für die Zeit 01.11.2024 - 31.10.2026 ↗DAK-Gesundheitshared awardawarded 1 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bosutinib, ATC L01EA04 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bosutinib, ATC L01EA04 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 1 Oct 2024
- 101 - DAK / KKH - Colecalciferol - A11CC05 (TEI) ↗DAK-Gesundheitshared awardawarded 10 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Brinzolamid + Brimonidin, ATC S01EC24 für die Zeit 01.09.2024 - 31.08.2026 ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Generika-Ersatzkassen 20 ↗DAK-Gesundheitshared awardawarded 31 Aug 2024
- Germany – Pharmaceutical products – GWQ-Generika-Ausschreibung Rivaroxaban 2,5 mg FTA Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 27 Aug 2024
- Rivaroxaban 2,5 mg FTA ↗GWQ ServicePlus AGshared awardawarded 26 Aug 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.